Literature DB >> 9502551

A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients.

C Zalewski1, M T Johnson-Selfridge, S Ohriner, K Zarrella, J C Seltzer.   

Abstract

This review examines the literature on neuropsychological differences between paranoid and nonparanoid schizophrenia subjects. Thirty-two studies related to intellectual functioning, attention, memory, language, visual-spatial, and motor functions are discussed. Subjects with paranoid schizophrenia did not demonstrate higher intellectual functioning than those with nonparanoid schizophrenia, and both groups performed similarly on tests of verbal ability and visual-spatial functions. Several studies suggest that the paranoid subtype is associated with higher performance on tests of executive functions, attention, memory, and motor skills. However, the findings are inconsistent. Methodological issues in the literature are examined, including varying degrees of participants' chronicity and severity of illness among studies, criteria for diagnostic group membership, medication effects, reliability and validity of the neuropsychological measures, and statistical power.

Entities:  

Mesh:

Year:  1998        PMID: 9502551     DOI: 10.1093/oxfordjournals.schbul.a033305

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  12 in total

Review 1.  Profiles of neuropsychologic function in schizophrenia.

Authors:  J Daniel Ragland
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

Review 2.  The Imbalanced Plasticity Hypothesis of Schizophrenia-Related Psychosis: A Predictive Perspective.

Authors:  Yossi Guterman; Yochai Ataria; Steven M Silverstein
Journal:  Cogn Affect Behav Neurosci       Date:  2021-05-28       Impact factor: 3.282

3.  Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes.

Authors:  S Kristian Hill; J Daniel Ragland; Ruben C Gur; Raquel E Gur
Journal:  J Clin Exp Neuropsychol       Date:  2002-09       Impact factor: 2.475

4.  Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study.

Authors:  Bin Ji; Wei Mei; John X Zhang; Juzhen Jing; Qiulin Wu; Yongning Zhuo; Zhuangwei Xiao
Journal:  Exp Brain Res       Date:  2013-07-03       Impact factor: 1.972

5.  Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.

Authors:  Kathryn E Lewandowski; Bruce M Cohen; Matcheri S Keshavan; Dost Ongür
Journal:  Schizophr Res       Date:  2011-10-12       Impact factor: 4.939

6.  Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex.

Authors:  Victoria S Dalton; Leonora E Long; Cyndi Shannon Weickert; Katerina Zavitsanou
Journal:  Neuropsychopharmacology       Date:  2011-04-06       Impact factor: 7.853

7.  Understanding delusions.

Authors:  Chandra Kiran; Suprakash Chaudhury
Journal:  Ind Psychiatry J       Date:  2009-01

8.  Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants.

Authors:  Hsien-Yuan Lane; Yue-Cune Chang; Chih-Chiang Chiu; Sue-Hong Lee; Cher-Yeang Lin; Wen-Ho Chang
Journal:  Psychopharmacology (Berl)       Date:  2003-12-09       Impact factor: 4.530

9.  Individual differences in the executive control of attention, memory, and thought, and their associations with schizotypy.

Authors:  Michael J Kane; Matt E Meier; Bridget A Smeekens; Georgina M Gross; Charlotte A Chun; Paul J Silvia; Thomas R Kwapil
Journal:  J Exp Psychol Gen       Date:  2016-06-16

10.  An epidemiological study of concomitant use of Chinese medicine and antipsychotics in schizophrenic patients: implication for herb-drug interaction.

Authors:  Zhang-Jin Zhang; Qing-Rong Tan; Yao Tong; Xue-Yi Wang; Huai-Hai Wang; Lai-Ming Ho; Hei Kiu Wong; Yi-Bin Feng; Di Wang; Roger Ng; Grainne M McAlonan; Chuan-Yue Wang; Vivian Taam Wong
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.